Investors pump $6.6m into Omeicos

Apr 17, 2015 • Candy Chan

The biopharmaceutical company, the developer of a treatment for atrial fibrillation, raised the cash from investors including industrial corporate SMS.

Germany-based biopharmaceutical company Omeicos Therapeutics raised €6.2m ($6.6m) in a series A round featuring SMS Group, a metallurgical plant operator and mechanical engineering firm, on Wednesday.

The round was led by mid-stage investment fund Vesalius Biocapital Partners with the participation of venture capital fund VC Fonds Technology Berlin, public-private venture capital investment firm High-Tech Gruenderfonds (HTGF), and German state-owned development bank KfW Group.

Omeicos is developing a novel molecule for the treatment and prevention of heart disorder atrial fibrillation.

HTGF previously supplied an undisclosed amount of seed funding to Omeicos in 2012. The company has also received €550,000 from Ascenion’s Spinnovator, a grant programme supported by the German Ministry of Education and Research.

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

The CVC Funding Round Database

Realtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.

CVC Directory

Full details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.

Corporate venture building report

Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes

Events

All events

About us

GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.

Navigation

test reg